0001209191-23-015524.txt : 20230303
0001209191-23-015524.hdr.sgml : 20230303
20230303163133
ACCESSION NUMBER: 0001209191-23-015524
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230301
FILED AS OF DATE: 20230303
DATE AS OF CHANGE: 20230303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Struthers Richard Scott
CENTRAL INDEX KEY: 0001746298
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38583
FILM NUMBER: 23704645
MAIL ADDRESS:
STREET 1: C/O CRINETICS PHARMACEUTICALS, INC.
STREET 2: 10222 BARNES CANYON ROAD, BLDG. #2
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Crinetics Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001658247
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263744114
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10222 BARNES CANYON ROAD, BLDG. #2
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-450-6464
MAIL ADDRESS:
STREET 1: 10222 BARNES CANYON ROAD, BLDG. #2
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-03-01
0
0001658247
Crinetics Pharmaceuticals, Inc.
CRNX
0001746298
Struthers Richard Scott
C/O CRINETICS PHARMACEUTICALS, INC.
10222 BARNES CANYON ROAD, BLDG 2
SAN DIEGO
CA
92121
1
1
0
0
President & CEO
Common Stock
2023-03-01
4
A
0
61650
0.00
A
130150
D
Common Stock
1000
I
By Spouse
Common Stock
730805
I
By Family Trust 1
Common Stock
90000
I
By Family Trust 2
Common Stock
90000
I
By Family Trust 3
Common Stock
90000
I
By Family Trust 4
Common Stock (right to buy)
19.64
2023-03-01
4
A
0
287700
0.00
A
2033-02-28
Common Stock
287700
287700
D
The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 25% vesting annually beginning on March 15, 2024.
The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of March 1, 2023.
/s/ Marc Wilson, as attorney-in-fact
2023-03-03